c-Src facilitates tumorigenesis by phosphorylating and activating G6PD

Oncogene. 2021 Apr;40(14):2567-2580. doi: 10.1038/s41388-021-01673-0. Epub 2021 Mar 8.

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) is the first and rate-limiting enzyme in pentose phosphate pathway (PPP), excessive activation of which has been considered to be involved in tumorigenesis. Here, we show that tyrosine kinase c-Src interacts with and phosphorylates G6PD at Tyr 112. This phosphorylation enhances catalytic activity of G6PD by dramatically decreasing its Km value and increasing its Kcat value for substrate glucose-6-phosphate. Activated G6PD therefore augments the PPP flux for NADPH and ribose-5-phosphate production which is required for detoxification of intracellular reactive oxygen species (ROS) and biosynthesis of cancer cells, and eventually contributes to tumorigenesis. Consistently, c-Src activation is closely correlated with tyrosine phosphorylation and activity of G6PD in clinical colorectal cancer samples. We thus uncover another aspect of c-Src in promoting cell proliferation and tumorigenesis, deepening our understanding of c-Src as a proto-oncogene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CSK Tyrosine-Protein Kinase / metabolism*
  • Carcinogenesis
  • Cell Growth Processes / physiology
  • Colorectal Neoplasms / enzymology*
  • Colorectal Neoplasms / pathology
  • Enzyme Activation
  • Glucosephosphate Dehydrogenase / metabolism*
  • HCT116 Cells
  • HEK293 Cells
  • HeLa Cells
  • Heterografts
  • Humans
  • Lipids / biosynthesis
  • Male
  • Mice
  • Mice, Nude
  • NADP / metabolism
  • Phosphorylation
  • Proto-Oncogene Mas

Substances

  • Lipids
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • NADP
  • G6PD protein, human
  • Glucosephosphate Dehydrogenase
  • CSK Tyrosine-Protein Kinase
  • CSK protein, human